Hong Yun Zhang

Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China.